Article Information
History
- July 9, 2021.
Article Versions
- Version 1 (July 7, 2021 - 21:25).
- You are currently viewing Version 2 of this article (July 9, 2021 - 12:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mai M. Abdelmoaty1,2,
- Pravin Yeapuri1,
- Jatin Machhi3,
- Katherine E. Olson3,
- Farah Shahjin3,
- You Zhou4,
- Liang Jingjing3,
- Kabita Pandey3,
- Arpan Acharya3,
- Siddappa N. Byrareddy3,
- R. Lee Mosley3 and
- Howard E. Gendelman3,*
- 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, NE 68198, USA
- 2Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt
- 3Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, NE 68198, USA
- 4Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USA
- ↵*Corresponding author:
Howard E. Gendelman, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800; phone 402-559-8920; fax 402-559-3744; email hegendel{at}unmc.edu